Search research articles
Contact Us
Filters
Showing results (1-10 of 52) with videos related to
Page
of 6
Sort By:
Circulation
|
March 7, 2012
Letter by Knop regarding article, "Effect of torcetrapib on glucose, insulin, and hemoglobin A1c in subjects in the investigation of lipid level management to understand its impact in atherosclerotic events (ILLUMINATE) trial"
F K Knop
Diabetologia
|
September 4, 2009
Resolution of type 2 diabetes following gastric bypass surgery: involvement of gut-derived glucagon and glucagonotropic signalling?
F K Knop
Endoscopy
|
June 25, 2003
Small-bowel hemangiosarcoma and capsule endoscopy
F K Knop, M B Hansen, S Meisner
Diabetes, Obesity & Metabolism
|
September 29, 2011
Current evidence for a role of GLP-1 in Roux-en-Y gastric bypass-induced remission of type 2 diabetes
N A Rhee, T Vilsbøll, F K Knop
Drugs of Today (Barcelona, Spain : 1998)
|
October 3, 2013
Lixisenatide for the treatment of type 2 diabetes
A B Petersen, F K Knop, M Christensen
Current Diabetes Reports
|
December 25, 2015
GLP-1 and Amylin in the Treatment of Obesity
T Jorsal, J Rungby, F K Knop, et al.
Diabetes, Obesity & Metabolism
|
May 11, 2016
Diabetes and obesity treatment based on dual incretin receptor activation: 'twincretins'
M A Skow, N C Bergmann, F K Knop
Diabetes, Obesity & Metabolism
|
January 29, 2016
Effect of antibiotics on gut microbiota, glucose metabolism and body weight regulation: a review of the literature
K H Mikkelsen, K H Allin, F K Knop
Medical & Biological Engineering & Computing
|
October 24, 2015
A comprehensive compartmental model of blood glucose regulation for healthy and type 2 diabetic subjects
O Vahidi, K E Kwok, R B Gopaluni, et al.
International Journal of Clinical Practice
|
July 24, 2009
Treatment of type 2 diabetes with glucagon-like peptide-1 receptor agonists
K B Hansen, F K Knop, J J Holst, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 52) with videos related to
Sort By:
Page
of 6
Circulation
|
March 7, 2012
Letter by Knop regarding article, "Effect of torcetrapib on glucose, insulin, and hemoglobin A1c in subjects in the investigation of lipid level management to understand its impact in atherosclerotic events (ILLUMINATE) trial"
F K Knop
Diabetologia
|
September 4, 2009
Resolution of type 2 diabetes following gastric bypass surgery: involvement of gut-derived glucagon and glucagonotropic signalling?
F K Knop
Endoscopy
|
June 25, 2003
Small-bowel hemangiosarcoma and capsule endoscopy
F K Knop, M B Hansen, S Meisner
Diabetes, Obesity & Metabolism
|
September 29, 2011
Current evidence for a role of GLP-1 in Roux-en-Y gastric bypass-induced remission of type 2 diabetes
N A Rhee, T Vilsbøll, F K Knop
Drugs of Today (Barcelona, Spain : 1998)
|
October 3, 2013
Lixisenatide for the treatment of type 2 diabetes
A B Petersen, F K Knop, M Christensen
Current Diabetes Reports
|
December 25, 2015
GLP-1 and Amylin in the Treatment of Obesity
T Jorsal, J Rungby, F K Knop, et al.
Diabetes, Obesity & Metabolism
|
May 11, 2016
Diabetes and obesity treatment based on dual incretin receptor activation: 'twincretins'
M A Skow, N C Bergmann, F K Knop
Diabetes, Obesity & Metabolism
|
January 29, 2016
Effect of antibiotics on gut microbiota, glucose metabolism and body weight regulation: a review of the literature
K H Mikkelsen, K H Allin, F K Knop
Medical & Biological Engineering & Computing
|
October 24, 2015
A comprehensive compartmental model of blood glucose regulation for healthy and type 2 diabetic subjects
O Vahidi, K E Kwok, R B Gopaluni, et al.
International Journal of Clinical Practice
|
July 24, 2009
Treatment of type 2 diabetes with glucagon-like peptide-1 receptor agonists
K B Hansen, F K Knop, J J Holst, et al.
Page
of 6